WO2026115441 - ANTIOXIDANT OPHTHALMIC EMULSION
National phase entry is expected:
Publication Number
WO/2026/115441
Publication Date
04.06.2026
International Application No.
PCT/IB2025/062063
International Filing Date
25.11.2025
Title **
[English]
ANTIOXIDANT OPHTHALMIC EMULSION
[French]
ÉMULSION OPHTALMIQUE ANTIOXYDANTE
Applicants **
ALCON INC.
Inventors
KAMAL, Mohammad Mostafa
WEN, Jianheng
HONG, Ye
Priority Data
63/726,076
27.11.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2023 | |
| EPO | Filing, Examination, Granting | 8163 | |
| Japan | Filing, Examination, Granting | 2171 | |
| South Korea | Filing, Examination, Granting | 2057 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
19,154
Contact Us
Abstract[English]
The present invention is directed to an antioxidant ophthalmic emulsion. More particularly, the present invention is directed to an ophthalmic emulsion having a unique combination of ingredients that promotes the transparent property of small oil droplets within the emulsion and promotes the therapeutic delivery capability of the emulsion.[French]
La présente invention concerne une émulsion ophtalmique antioxydante. Plus particulièrement, la présente invention concerne une émulsion ophtalmique présentant une combinaison unique d'ingrédients favorisant la propriété de transparence de petites gouttelettes d'huile au sein de l'émulsion et favorisant la capacité d'administration thérapeutique de l'émulsion.